Establishment and external validation of an early warning model of diabetic peripheral neuropathy based on random forest and logistic regression
Open Access
- 20 September 2024
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 24 (1) , 1-14
Abstract
The primary objective of this study was to investigate the risk factors for diabetic peripheral neuropathy (DPN) and to establish an early diagnostic prediction model for its onset, based on clinical data and biochemical indices. Retrospective data were collected from 1,446 diabetic patients at the First Affiliated Hospital of Anhui University of Chinese Medicine and were split into training and internal validation sets in a 7:3 ratio. Additionally, 360 diabetic patients from the Second Affiliated Hospital were used as an external validation cohort. Feature selection was conducted within the training set, where univariate logistic regression identified variables with a p-value < 0.05, followed by backward elimination to construct the logistic regression model. Concurrently, the random forest algorithm was applied to the training set to identify the top 10 most important features, with hyperparameter optimization performed via grid search combined with cross-validation. Model performance was evaluated using ROC curves, decision curve analysis, and calibration curves. Model fit was assessed using the Hosmer-Lemeshow test, followed by Brier Score evaluation for the random forest model. Ten-fold cross-validation was employed for further validation, and SHAP analysis was conducted to enhance model interpretability. A nomogram model was developed using logistic regression with key features: limb numbness, limb pain, diabetic retinopathy, diabetic kidney disease, urinary protein, diastolic blood pressure, white blood cell count, HbA1c, and high-density lipoprotein cholesterol. The model achieved AUCs of 0.91, 0.88, and 0.88 for the training, validation, and test sets, respectively, with a mean AUC of 0.902 across 10-fold cross-validation. Hosmer-Lemeshow test results showed p-values of 0.595, 0.418, and 0.126 for the training, validation, and test sets, respectively. The random forest model demonstrated AUCs of 0.95, 0.88, and 0.88 for the training, validation, and test sets, respectively, with a mean AUC of 0.886 across 10-fold cross-validation. The Brier score indicates a good calibration level, with values of 0.104, 0.143, and 0.142 for the training, validation, and test sets, respectively. The developed nomogram exhibits promise as an effective tool for the diagnosis of diabetic peripheral neuropathy in clinical settings.Keywords
Funding Information
- Key Research and Development Program of Anhui Province ((No.202104j07020006))
- National Natural Science Foundation of China ((No.81874457))
- Scientific Research Project of higher education in Anhui Province ((No.2022AH050480))
This publication has 38 references indexed in Scilit:
- The role of aberrant mitochondrial bioenergetics in diabetic neuropathyNeurobiology of Disease, 2013
- Mechanisms of Diabetic ComplicationsPhysiological Reviews, 2013
- Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsDiabetic Medicine, 2012
- Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicityBrain Research, 2011
- The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathyJournal of Vascular Surgery, 2009
- Dyslipidemia-Induced Neuropathy in MiceDiabetes, 2009
- Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathyDiabetic Medicine, 2009
- Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes StudyDiabetologia, 2008
- Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?Pediatric Diabetes, 2007
- Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications StudyDiabetologia, 1996